Tianshu Pharmaceutical Recognized as "2025 Hubei Provincial Small and Medium-sized Enterprise Technology Center"

Recently, the Hubei Provincial Department of Economy and Information Technology announced the list of recognized "2025 Hubei Provincial Small and Medium-sized Enterprise Technology Centers". Hubei Tianshu Pharmaceutical Co., Ltd. (Tianshu Pharmaceutical) was successfully selected relying on three major technology platforms: chiral drug synthesis and analysis technology, bioenzyme engineering technology, and continuous flow engineering technology.

The selection of Hubei Provincial Small and Medium-sized Enterprise Technology Centers aims to encourage enterprises to strengthen technological innovation, enhance core competitiveness, and promote high-quality industrial development. Centering on the corporate vision of "becoming a world-class supplier of APIs and advanced intermediates and a comprehensive solution provider", Tianshu Pharmaceutical has always adhered to innovation-driven development, with differentiated technology as the core. It actively explores greener, safer, and more intelligent advanced engineering technologies in the biomedical field, such as continuous flow, micro-packed bed, metal catalysis, and bioenzyme catalysis, realizing safe, efficient, green, and environmentally friendly pharmaceutical production processes, and continuously providing more efficient, high-quality, and low-cost products and services for customers.

　　This successful selection signifies that Tianshu Pharmaceutical's technological innovation capability and core competitiveness have been officially recognized, which will inject new impetus into the development of the pharmaceutical industry in Xiangyang City and even Hubei Province.